November marks Pancreatic Cancer Awareness Month, a dedicated period to cast a spotlight on a disease that often operates in the shadows. November is a special month for everyone affected by pancreatic cancer. It is our opportunity to elevate our voices to raise awareness, it is a time to educate the world by sharing our stories and support research. Let’s come together, speak up and show our determination to never give up.

Understanding Pancreatic Cancer 

Pancreatic cancer diagnosis is a formidable adversary, often identified at advanced stages, making it one of the most challenging cancers to treat effectively. The pancreas is located behind the stomach. It plays a vital role in digestion and also blood sugar regulation. Pancreatic cancer arises when abnormal cells uncontrollably multiply within the pancreas, forming tumors. A new study found that it takes about 7 years for a pancreatic tumor to become sizable and around 10 years for that tumor to metastasize or spread to other parts of the body. The lack of early symptoms and efficient screening methods intensifies the urgency for increased awareness.

The Impact of Pancreatic Cancer 

Numbers tell a clear story — pancreatic cancer is one of the most deadly cancers with a very low survival rate. Every year, thousands face the impact of this disease and their lives are changed forever. Stories from real people show the emotional and physical toll on patients and their families. This highlights the urgent need for more awareness and increased research to change the path of pancreatic cancer.

Pancreatic Cancer Risk Factors and Prevention 

Understanding the pancreatic cancer risk factors is crucial for prevention. Age, family history and smoking are common risk factors associated with pancreatic cancer. Only about 1 in 5 individuals have a tumor that can be surgically removed. Even among that subset, pancreatic cancer rebounds 75% of the time. Right now, surgery is the best way to treat pancreatic cancer. But, most patients are diagnosed at later stages and are not eligible for surgery. We urgently need to develop tools and tests for early detection of pancreatic cancer. Lifestyle changes, such as adopting a healthy diet and regular exercise, contribute to prevention. We’re still learning how these factors affect pancreatic cancer, but starting with a healthy lifestyle is the first step to overall well-being. Increasing awareness of these factors empowers individuals to take proactive measures in reducing their susceptibility to this insidious disease.

Depending on the type and stage of the cancer, as well as other factors, treatment options for people with pancreatic cancer can involve surgery of the pancreas, ablation or embolization treatments, radiation therapy, chemotherapy, targeted therapy and immunotherapy.

Pancreatic Cancer Symptoms and Early Detection

Common indicators include abdominal pain, unexplained weight loss and jaundice. Given the subtlety of these signs, it is imperative for individuals to remain vigilant and promptly seek medical attention. While effective screening tools are currently limited, awareness of symptoms remains an important weapon in the ongoing battle against pancreatic cancer. If you notice any of these signs, don’t hesitate to contact your doctor for a thorough evaluation.

TrovaNow’s Role in Pancreatic Cancer Awareness 

In its mission to raise awareness about pancreatic cancer, TrovaNow is dedicated to supporting initiatives like the PRECEDE Consortium. Recognizing the vital role of collaborative efforts in advancing early detection and prevention strategies for pancreatic cancer, TrovaNow actively promotes the dissemination of new protocols and discoveries from the PRECEDE Consortium.

This groundbreaking initiative, an observational longitudinal prospective cohort study, unites clinicians, researchers, patients and industry leaders to accelerate innovative approaches for pancreatic cancer early detection and prevention.

By supporting a technology-rich and data-driven model of research, TrovaNow aims to amplify the impact of pancreatic cancer early detection and prevention efforts. Through initiatives like the PRECEDE Consortium, TrovaNow maximizes the identification of high-risk individuals, advances research and contributes to strategic plans for pancreatic cancer prevention.

As Pancreatic Cancer Awareness Month progresses, let’s reflect on the importance of united action. Understanding the challenges and supporting campaigns can collectively contribute to the ongoing battle against pancreatic cancer. Together, we can make strides toward early detection, improved treatments and ultimately, better outcomes for those facing this tough challenge.

To align with TrovaNow’s commitment to advancing pancreatic cancer awareness, consider exploring and sharing information about initiatives like the PRECEDE Consortium. Engage with TrovaNow’s platform to stay updated on the latest protocols and discoveries in pancreatic cancer research.

Actively participating in Pancreatic Cancer Awareness Month allows us to bring hope, support and progress to those affected by this silent killer. Joining events, sharing posts on social media and participating in local fundraisers all make a big difference, contributing to the collective effort in the ongoing battle against pancreatic cancer.

Donate To Pancreatic Cancer Research

Pancreatic cancer remains one of the top 3 cancer-related causes of death in the US and its incidence continues to rise, with a projected 50,000+ deaths by the end of this year. Pancreatic cancer survival rates show the percentage of people who live for at least 5 years after being diagnosed. The good news is, over time, the chance of the cancer coming back usually goes down. But remember, this varies for each person and type of cancer. At TrovaNow, we’re determined to change this trajectory. Committed to collaborative research to enhance pancreatic cancer early detection and prevention, our goal is to elevate the 5-year pancreatic cancer survival rate from 12% to 50% in the next decade.

With your help and donations, our research and data sharing can change the outcomes for patients diagnosed with pancreatic cancer. While pancreatic cancer is often considered the most lethal cancer in the human body, new treatment advances are improving outcomes for patients, offering the possibility of long-term survival. Discover more about how pancreatic cancer patients are prioritizing quality of life and contributing to advancements in pancreatic cancer treatment through research.

Visit www.trovanow.com to learn how you can get involved and donate today, joining us in the mission to make a meaningful impact on pancreatic cancer outcomes.